Astellas Pharma US, Inc. and The International Transplant Nurses Society (ITNS) Collaborate on Content for Transplant Experien... ( Educational program offers unique re...)

HOME >> BIOLOGY >> TECHNOLOGY

Astellas Pharma US, Inc. and The International Transplant Nurses Society (ITNS) Collaborate on Content for Transplant Experience Program

Date:10/17/2007

Educational program offers unique resources to empower transplant patients

and their caregivers

DEERFIELD, Ill., Oct. 17 /PRNewswire-FirstCall/ -- Astellas Pharma US, Inc. (Pink Sheets: ALPMF), a leader in the field of transplantation, and The International Transplant Nurses Society (ITNS), a leading transplant professional organization, announced a collaborative partnership to jointly develop further materials for the multi-award-winning Transplant Experience program -- a comprehensive, educational resource for the transplant community.

"The International Transplant Nurses Society (ITNS) endorses the Transplant Experience program and is proud to be a collaborative partner with Astellas," said Beth A. Kassalen, Executive Director of ITNS. "We are excited to be able to develop materials that empower organ transplant recipients and their caregivers to take a more active role in their treatment and long-term health."

The Transplant Experience program offers a variety of tools to help empower patients and caregivers, providing resources throughout every stage of the transplant experience: pre-transplant, the first year after a transplant, and beyond. The program includes, tools, tips and also provides peer-to-peer information from transplant recipients. Materials are available at http://www.TransplantExperience.com or by calling 1-800-466-9191, and include:

-- Welcome kit, including an inspirational video, a personal treatment

journal and a unique pill box to help patients organize and carry their

medicines

-- Helpful information sent directly to patients throughout the year,

including newsletters, emails, videos, special gifts and more

-- Regular updates on news and events in the transplant community

-- Shared stories of challenges and successes

-- Tools and advice to help patients achieve long-ter
'/>"/>

0

GOOD

Page: 1 2 3
Related biology technology :

1. Analyzing Trace-Level Impurities of a Pharmaceutical Intermediate Using an LCQ Deca Ion Trap Mass Spectrometer and the Mass Frontier Software Package
2. Rapid SNP Genotyping of the Pharmacogenomically Important Allele CYP2D6*4 Using Real-Time qPCR on the DNA Engine Opticon 2 System
3. Development of a sensitive enzyme fragment complementation assay for cyclic adenosine 3, 5 monophosphate and its validation for pharmacological screening at G protein-coupled receptors
4. Practical Applications of HyperDSC in a Pharmaceutical Laboratory
5. World Class Life Science and Pharmaceutical Companies Leverage DoveBid s Global Reach for Asset Management and Disposition
6. Germantown drug company hires pharma veteran James Davidson as COO
7. Deltanoid Pharmaceuticals begins phase II osteoporosis study
8. New angel capital centered on GenTel agreement with big pharma
9. The deconstruction of Big Pharma
10. Big pharma seeks Wisconsin biotech partnerships
11. Doing the pharmaceutical tango

Post Your Comments:

Astellas Pharma US, Inc. and The International Transplant Nurses Society (ITNS) Collaborate on Content for Transplant Experien...( Educational program offers unique re...)